Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency - Katakura, Yukino; Kimura, Tomohiko; Kusano, Takashi; Tatsumi, Fuminori; Iwamoto, Yuichiro; Sanada, Junpei; Fushimi, Yoshiro; Shimoda, Masashi; Kohara, Kenji; Nakanishi, Shuhei; Kaku, Kohei; Mune, Tomoatsu; et al. (Frontiers in endocrinology (Lausanne), 2021)
Keywords: Adrenocorticotropic Hormone - deficiency; Antineoplastic Agents, Immunological - administration & dosage; Antineoplastic Agents, Immunological - adverse effects; Antineoplastic Combined Chemotherapy Protocols; aseptic meningitis; Atrophy - chemically induced; destructive thyroiditis; Endocrine System Diseases - chemically induced; Endocrine System Diseases - diagnosis; Endocrinology; Genetic Diseases, Inborn - chemically induced; Genetic Diseases, Inborn - diagnosis; Humans; Hypoglycemia - chemically induced; Hypoglycemia - diagnosis; immune checkpoint inhibitor; Immune Checkpoint Inhibitors - administration & dosage; Immune Checkpoint Inhibitors - adverse effects; immune-related adverse event; Ipilimumab - administration & dosage; Ipilimumab - adverse effects; isolated ACTH deficiency; Japan; Male; Melanoma - drug therapy; Melanoma, Cutaneous Malignant; Meningitis, Aseptic - chemically induced; Meningitis, Aseptic - diagnosis; Middle Aged; Nivolumab - administration & dosage; Nivolumab - adverse effects; Skin Neoplasms - drug therapy; Thyroid Gland - drug effects; Thyroid Gland - pathology; Thyroiditis - chemically induced; Thyroiditis - diagnosis; Thyroiditis - pathology; Japan; isolated ACTH deficiency; immune checkpoint inhibitor; aseptic meningitis; destructive thyroiditis; immune-related adverse event